June 2015
Volume 56, Issue 7
ARVO Annual Meeting Abstract  |   June 2015
Survival and efficacy of xenogeneic cell transplants in the RCS rat in the absence of immunosuppression
Author Affiliations & Notes
  • Trevor J McGill
    Neuroscience, Oregon National Primate Research Center, Beaverton, OR
    Casey Eye Institute, Oregon Health and Science University, Portland, OR
  • Shaomei Wang
    Biomedical Sciences, Cedar Sinai, Los Angeles, CA
  • Bin Lu
    Biomedical Sciences, Cedar Sinai, Los Angeles, CA
  • Stephen Huhn
    StemCells, Inc., Newark, CA
  • Raymond D Lund
    Moran Eye Center, Salt Lake City, UT
  • Alexandra Capela
    StemCells, Inc., Newark, CA
  • Footnotes
    Commercial Relationships Trevor McGill, None; Shaomei Wang, None; Bin Lu, None; Stephen Huhn, StemCells Inc (E); Raymond Lund, None; Alexandra Capela, StemCells Inc (E)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 2357. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Trevor J McGill, Shaomei Wang, Bin Lu, Stephen Huhn, Raymond D Lund, Alexandra Capela; Survival and efficacy of xenogeneic cell transplants in the RCS rat in the absence of immunosuppression. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):2357.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: Age-related Macular Degeneration (AMD) is the primary cause of visual impairment in industrialized countries for which no cure is available. Transplantation of cells into the subretinal space (SRS) is a promising experimental neuroprotective treatment for dry AMD which is currently under clinical investigation. Although the normal SRS is considered to be relatively immunoprivileged, it is unclear how this privilege is affected by degeneration; therefore, ongoing clinical studies with allogeneic cells currently include immunosuppression. Preclinical studies in the RCS rat have demonstrated that, with the aid of continuous immunosuppression, donor xenogeneic cells survive transplantation, rescue photoreceptors and limit the associated loss of vision. The purpose of this study was to examine the survival and efficacy of human neural stem cells (HuCNS-SC) following transplantation under non continuous or even absent immunosuppression.

Methods: HuCNS-SC (1x105) were transplanted into the SRS of one eye of 38 RCS rats on post-natal day (P) 21. Thirteen (13) contralateral eyes served as medium-injected controls, and twenty-five (25) eyes were maintained as unoperated controls. The 38 animals were divided into four groups: no immunosuppression (Group A; n=8); two weeks of dexamethasone (DEX) (Group B; n=12); 2 weeks of DEX and 30 days of cyclosporine (Group C; n=11); and 2 weeks of DEX and continuous cyclosporine (Group D; n=7), the immunosuppression used in our previous preclinical studies. Visual acuity was measured through optokinetic tracking (OKR) at 30 day intervals. Retinal histology was performed following sacrifice at either P90 or P150.

Results: OKRs were maintained in all cell treated eyes at all time points. Control eyes degenerated consistent with previously reported values. Surprisingly, transplanted cells survived in all groups despite the lack of immunosuppression in some animals. One animal in Group C exhibited graft rejection evident by a mononuclear response. Photoreceptor rescue was observed in all groups as evidenced by an outer nuclear layer thickness of 6-10 nuclei at both P90 and P150, consistent with our previously published data.

Conclusions: Our results demonstrate that xenogeneic HuCNS-SC can survive and rescue function in the RCS rat in the absence of immunosuppression.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.